{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T00:38:36Z","timestamp":1759451916757,"version":"build-2065373602"},"reference-count":29,"publisher":"Elsevier BV","issue":"40","license":[{"start":{"date-parts":[[2011,9,1]],"date-time":"2011-09-01T00:00:00Z","timestamp":1314835200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,9,1]],"date-time":"2011-09-01T00:00:00Z","timestamp":1314835200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2011,9,1]],"date-time":"2011-09-01T00:00:00Z","timestamp":1314835200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2011,9,1]],"date-time":"2011-09-01T00:00:00Z","timestamp":1314835200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2011,9,1]],"date-time":"2011-09-01T00:00:00Z","timestamp":1314835200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2011,9,1]],"date-time":"2011-09-01T00:00:00Z","timestamp":1314835200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2011,9,1]],"date-time":"2011-09-01T00:00:00Z","timestamp":1314835200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2011,9]]},"DOI":"10.1016\/j.vaccine.2011.07.028","type":"journal-article","created":{"date-parts":[[2011,7,29]],"date-time":"2011-07-29T09:54:33Z","timestamp":1311933273000},"page":"7058-7066","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Development of an interferon-gamma ELISPOT assay to detect human T cell responses to HSV-2"],"prefix":"10.1016","volume":"29","author":[{"given":"Christine M.","family":"Posavad","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amalia S.","family":"Magaret","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lin","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dawn E.","family":"Mueller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Wald","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lawrence","family":"Corey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2011.07.028_bib0005","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1001\/jama.296.8.964","article-title":"Trends in herpes simplex virus type 1 and type 2 seroprevalence in the United States","volume":"296","author":"Xu","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.vaccine.2011.07.028_bib0010","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1016\/S0140-6736(07)61908-4","article-title":"Genital herpes","volume":"370","author":"Gupta","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2011.07.028_bib0015","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1056\/NEJM199710163371601","article-title":"Herpes simplex virus type 2 in the United States, 1976 to 1994","volume":"337","author":"Fleming","year":"1997","journal-title":"NEJM"},{"key":"10.1016\/j.vaccine.2011.07.028_bib0020","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1097\/01.OLQ.0000123651.84697.D6","article-title":"Seroprevalence of herpes simplex virus-2 in suburban primary care offices in the United States","volume":"31","author":"Leone","year":"2004","journal-title":"Sex Transm Dis"},{"key":"10.1016\/j.vaccine.2011.07.028_bib0025","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1097\/01.aids.0000198081.09337.a7","article-title":"Herpes simplex virus 2 infection increases HIV acquisition in men and women: systematic review and meta-analysis of longitudinal studies","volume":"20","author":"Freeman","year":"2006","journal-title":"AIDS"},{"key":"10.1016\/j.vaccine.2011.07.028_bib0030","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1097\/00126334-200404150-00001","article-title":"The effects of herpes simplex virus-2 on HIV-1 acquisition and transmission: a review of two overlapping epidemics","volume":"35","author":"Corey","year":"2004","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1016\/j.vaccine.2011.07.028_bib0035","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1128\/CMR.17.1.1-13.2004","article-title":"Neonatal herpes simplex infection","volume":"17","author":"Kimberlin","year":"2004","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.vaccine.2011.07.028_bib0040","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1056\/NEJMoa011915","article-title":"Glycoprotein-D-adjuvant vaccine to prevent genital herpes","volume":"347","author":"Stanberry","year":"2002","journal-title":"NEJM"},{"key":"10.1016\/j.vaccine.2011.07.028_bib0045","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1128\/CVI.00167-08","article-title":"Phase I study of a DNA vaccine for herpes simplex virus type 2 (HSV-2) in healthy HSV-2 seronegative adults by a needle-free injection system","volume":"15","author":"Cattamanchi","year":"2008","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.vaccine.2011.07.028_bib0050","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1128\/CVI.00020-08","article-title":"Phase I dose-escalation study of a monovalent heat shock protein 70-herpes simplex virus type 2 (HSV-2) peptide-based vaccine designed to prime or boost CD8 T-cell responses in HSV-naive and HSV-2-infected subjects","volume":"15","author":"Koelle","year":"2008","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.vaccine.2011.07.028_bib0055","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1309\/AKWHF62YYJ054HA6","article-title":"Inaccuracy of certain commercial enzyme immunoassays in diagnosing genital infections with herpes simplex virus types 1 or 2","volume":"120","author":"Morrow","year":"2003","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.vaccine.2011.07.028_bib0060","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1186\/1471-2334-5-84","article-title":"Use of \u201cbiokit HSV-2 Rapid Assay\u201d to improve the positive predictive value of Focus HerpeSelect HSV-2 ELISA","volume":"5","author":"Morrow","year":"2005","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.vaccine.2011.07.028_bib0065","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1001\/jama.2008.697","article-title":"Cytomegalovirus reactivation in critically ill immunocompetent patients","volume":"300","author":"Limaye","year":"2008","journal-title":"JAMA"},{"key":"10.1016\/j.vaccine.2011.07.028_bib0070","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.jim.2007.02.003","article-title":"Defining blood processing parameters for optimal detection of cryopreserved antigen-specific responses for HIV vaccine trials","volume":"322","author":"Bull","year":"2007","journal-title":"J Immunol Methods"},{"key":"10.1016\/j.vaccine.2011.07.028_bib0075","doi-asserted-by":"crossref","first-page":"5509","DOI":"10.1128\/JVI.02659-05","article-title":"Diversity of the CD8+ T-cell response to herpes simplex virus type 2 proteins among persons with genital herpes","volume":"80","author":"Hosken","year":"2006","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2011.07.028_bib0080","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/1743-422X-3-54","article-title":"Characterization of the IFN-gamma T-cell responses to immediate early antigens in humans with genital herpes","volume":"3","author":"Braun","year":"2006","journal-title":"Virol J"},{"key":"10.1016\/j.vaccine.2011.07.028_bib0085","doi-asserted-by":"crossref","first-page":"3250","DOI":"10.4049\/jimmunol.0900722","article-title":"Detailed characterization of T cell responses to herpes simplex virus-2 in immune seronegative persons","volume":"184","author":"Posavad","year":"2010","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2011.07.028_bib0090","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0022-1759(01)00535-X","article-title":"A panel of MHC class I restricted viral peptides for use as a quality control for vaccine trial ELISPOT assays","volume":"260","author":"Currier","year":"2002","journal-title":"J Immunol Methods"},{"key":"10.1016\/j.vaccine.2011.07.028_bib0095","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.jim.2006.07.015","article-title":"Statistical positivity criteria for the analysis of ELISpot assay data in HIV-1 vaccine trials","volume":"315","author":"Moodie","year":"2006","journal-title":"J Immunol Methods"},{"key":"10.1016\/j.vaccine.2011.07.028_bib0100","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.jim.2007.03.002","article-title":"Optimization and validation of an 8-color intracellular cytokine staining (ICS) assay to quantify antigen-specific T cells induced by vaccination","volume":"323","author":"Horton","year":"2007","journal-title":"J Immunol Methods"},{"key":"10.1016\/j.vaccine.2011.07.028_bib0105","doi-asserted-by":"crossref","first-page":"6604","DOI":"10.4049\/jimmunol.181.9.6604","article-title":"Immunodominant epitopes in herpes simplex virus type 2 glycoprotein D are recognized by CD4 lymphocytes from both HSV-1 and HSV-2 seropositive subjects","volume":"181","author":"Kim","year":"2008","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2011.07.028_bib0110","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1093\/infdis\/169.5.956","article-title":"Direct recovery of herpes simplex virus (HSV)-specific T lymphocyte clones from recurrent genital HSV-2 lesions","volume":"169","author":"Koelle","year":"1994","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2011.07.028_bib0115","doi-asserted-by":"crossref","first-page":"8165","DOI":"10.1128\/jvi.70.11.8165-8168.1996","article-title":"High frequency of CD8+ cytotoxic T-lymphocyte precursors specific for herpes simplex viruses in persons with genital herpes","volume":"70","author":"Posavad","year":"1996","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2011.07.028_bib0120","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1128\/jvi.66.3.1622-1634.1992","article-title":"Human CD8+ herpes simplex virus-specific cytotoxic T-lymphocyte clones recognize diverse virion protein antigens","volume":"66","author":"Tigges","year":"1992","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2011.07.028_bib0125","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1093\/gerona\/gln012","article-title":"Socioeconomic and race\/ethnic patterns in persistent infection burden among U.S. adults","volume":"64A","author":"Zajacova","year":"2009","journal-title":"J Gerontol: A Biol Sci Med Sci"},{"key":"10.1016\/j.vaccine.2011.07.028_bib0130","doi-asserted-by":"crossref","first-page":"4380","DOI":"10.4049\/jimmunol.170.8.4380","article-title":"T cell immunity to herpes simplex viruses in seronegative subjects: silent infection or acquired immunity?","volume":"170","author":"Posavad","year":"2003","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2011.07.028_bib0135","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1093\/infdis\/165.6.1012","article-title":"Cell-mediated immune response to human immunodeficiency virus (HIV) type 1 in seronegative homosexual men with recent sexual exposure to HIV-1","volume":"165","author":"Clerici","year":"1992","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2011.07.028_bib0140","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1038\/nm1197-1250","article-title":"HIV-specific mucosal and cellular immunity in HIV-seronegative partners of HIV-seropositive individuals","volume":"3","author":"Mazzoli","year":"1997","journal-title":"Nat Med"},{"key":"10.1016\/j.vaccine.2011.07.028_bib0145","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1016\/0140-6736(93)93063-7","article-title":"HIV-specific cytotoxic T cell activity in an HIV-exposed but uninfected infant","volume":"341","author":"Rowland-Jones","year":"1993","journal-title":"Lancet"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X11010498?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X11010498?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:20:52Z","timestamp":1759400452000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X11010498"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,9]]},"references-count":29,"journal-issue":{"issue":"40","published-print":{"date-parts":[[2011,9]]}},"alternative-id":["S0264410X11010498"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2011.07.028","relation":{},"ISSN":["0264-410X"],"issn-type":[{"type":"print","value":"0264-410X"}],"subject":[],"published":{"date-parts":[[2011,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development of an interferon-gamma ELISPOT assay to detect human T cell responses to HSV-2","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2011.07.028","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}